Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Gross Margin (2016 - 2026)

Rockwell Medical filings provide 16 years of Gross Margin readings, the most recent being 21.14% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 642.0% to 21.14% in Q4 2025 year-over-year; TTM through Dec 2025 was 16.89%, a 34.0% decrease, with the full-year FY2025 number at 16.89%, down 34.0% from a year prior.
  • Gross Margin hit 21.14% in Q4 2025 for Rockwell Medical, up from 14.27% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 22.03% in Q3 2024 to a low of 14.55% in Q4 2021.
  • Median Gross Margin over the past 5 years was 12.55% (2022), compared with a mean of 9.06%.
  • Biggest five-year swings in Gross Margin: tumbled -1709bps in 2021 and later soared 2667bps in 2022.
  • Rockwell Medical's Gross Margin stood at 14.55% in 2021, then soared by 183bps to 12.12% in 2022, then rose by 7bps to 12.99% in 2023, then grew by 13bps to 14.72% in 2024, then soared by 44bps to 21.14% in 2025.
  • The last three reported values for Gross Margin were 21.14% (Q4 2025), 14.27% (Q3 2025), and 15.57% (Q2 2025) per Business Quant data.